ArticleBioactive materials2026
From disease model to therapeutic insight: An engineered hydrogel reveals the role of matrix viscous dissipation in intervertebral disc degeneration.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An All-in-One Au@CeOAdvanced healthcare materials · 2026Article
- Mechanotransduction in intervertebral disc degeneration: from compartment-specific sensors to translational frontiers.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intervertebral disc degeneration (IVDD) is a leading cause of low back pain. Although the mechanical functions of the nucleus pulposus (NP) critically relies on its viscous dissipation, the role of this property in IVDD remains unclear. Here, we established a correlation between reduced NP viscous dissipation and disease severity in both clinical specimens and a rat model. Using engineered hydrogels that independently mimic the viscous dissipation properties of healthy and degenerated NP, we found that decreased viscous dissipation induces NP cells (NPCs) senescence by suppressing YAP. Further mechanistic investigation revealed that NPCs likely sense changes in extracellular matrix (ECM) viscous dissipation primarily through ITGB1, which subsequently regulate cell adhesion and inhibit YAP activity. Downstream of YAP, reduced viscous dissipation leads to decreased nuclear envelope integrity and aberrant accumulation of cytosolic DNA in NPCs, thereby activating the cGAS-STING pathway and driving NPCs senescence. The senescence of NPCs induced by these events changed the components of ECM, which may further reduce viscous dissipation, potentially creating a vicious cycle. By pharmacological activation of YAP and the implantation of a mechanically biomimetic hydrogel, we alleviated the vicious cycle and suppressed IVDD progression
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.